World Pharmaceutical (China) Summit 2009 (WPCS2009)

Venue: Shanghai

Location: Shanghai, China

Event Date/Time: Sep 16, 2009 End Date/Time: Sep 18, 2009
Registration Date: Sep 15, 2009
Early Registration Date: Jun 10, 2009
Report as Spam

Description

Shanghai, the next seedbed for future discoveries, welcomes you to come and feel the pulse of the world's fastest growing CRO marketplace. InterContinental Shanghai Pudong PRC…September 16th – 18th, 2009…will welcome the opening of the World Pharmaceutical (China) Summit 2009(WPCS2009), expectedly a grand gathering of 300+ senior level executives from global pharmaceutical fraternity in China and elsewhere around the world. Delegates from all sectors of the pharmaceutical industry, including big pharmas; biotech companies; CROs; major hospitals; technology / equipment providers;capital owners, lawyers etc are attending and the swell of interest in this meaningful event has been remarkable!

ZJBPB and CFEC jointly organize “World Pharmaceutical (China) Summit 2009” (WPCS2009), looking forward to sharing with participants the latest development and achievements of the global pharmaceutical industry and exploring the industry's future prospects in China.

WPCS2009 boasts great support from CAP, SAPA, JPMA, Bayer, GSK, Roche, MSD, Eli Lilly, Pfizer, Johnson & Johnson, Kirin Pharmaceutial Novo Nordisk, Sanofi-Aventis, Takeda, Eisai, Abbott Laboratories, Novasep, DSM, Quintiles, PPD, Covance, Chemon, WuXi Pharma Tech, Sundia; ChemPartner, GenScript Corporation, FosunPharma, Hutchison MedPharma, Shanghai Pharmaceutical Group, North China Pharmaceutical Corporation, etc, featuring the official guideline presentations from Ministry of Health, PRC and State Intellectual Property Office, PRC.

WPCS2009 is one of the major international functions that link pharma executives from all over the world together. The theme of WPCS2009 on “Finding the Next Blockbuster and Turning Crisis into Opportunity” is particularly important to pharmaceutical MNCs striving for international cooperation for further growth. WPCS2009 will provide the most integrated platform for partnerships at both a strategic & technical level, and it will influence the whole China, even global pharmaceutical industry with positive and strong stimulation, herewith save the dates of September 16-18 on your 2009 calendar & secure your interest today!
WPCS2009 highlights:
 ONLY event to hold one-to-one meetings with policy makers from Ministry of Health, PRC, and State Intellectual Property Office, PRC and College of American Pathology
 ON-SITE visits to ZhangJiang Pharma Valley including DSM, Shanghai Hutchison Pharmaceuticals, Covance Central Laboratory and Sundia MediTech Company, Ltd.
 Project/product introduction meetings for Healthcare, Biotech, CRO and Hightech Parks
 UPDATES on China’s healthcare reform (basic medical insurance drup list, new drug registration policy, drug pricing adjustment, hospital bidding mechanism etc) and ‘National Major New Drug Innovation Fund’
 VALUE-ADDED workshop on IP strategies in new patent era
 INSIGHTS into the latest FDA/SFDA regulations
 VARIOUS focus points of pharma outsourcing and offshoring R&D
 SENSITIVE business issues & redhots facing pharmaceutical industry in global economic turmoil
 NEW financing structures that are emerging with liquidity drying up globally
 INTEGRATED platform for partnerships at both a strategic & technical level
WPCS2009 Agenda at a glance:
Day One - 16 September 2009, Wednesday / Pre-conference IP Tutorial IP STRATEGIES IN NEW PATENT ERA
13:00 Securing Global IP: Key Legal Considerations for Pharma R&D Outsourcing
14:00 How Pharmaceutical Companies May Best Protect their Trade Secrets in Cross Boarder Transactions?
15:00 Afternoon Refreshment
15:30 Contrasting European and U.S. Patent Laws: Pharmaceutical Patent Litigation and Settlements
16:30 Interactive Panel Discussion: IPR Issues and Challenges Relating to Drug Discovery in China
17:30 End of Workshop

Day Two - 17 September 2009, Thursday
0730 Registration – Coffee & Tea
0830 Chairman’s Welcome Address
Unleashing the Dragon: Fostering an Environment Conducive to Innovation & International Cooperation
0845 Government Policy Address
China’s Healthcare Reform and ‘National Major New Drug Innovation Fund’ to Support the Development of Pharmaceutical Industry
0930 Government Policy Address
What Should Pharmaceutical And Biotech Companies Know about the Third Revision of PRC Patent Law?
1015 Keynote Presentation
Improvements to the CAP Laboratory Accreditation Program (LAP)
1045 Coffee & Refreshment - Speed Networking Break
  “One-to-One” meetings with government officials
  Exchange business cards with fellow conference delegates and industry peers
1115 Keynote Presentation
“Showing his Regulatory Teeth” – Navigating through India Regulatory Terra Incoganita
1145 Keynote Presentation
Embedding FDA and SFDA Legislative Compliance into Daily Clinical Research Operations
1215 Keynote Presentation
Managing Multicenter Clinical Trial Operations in Key Asian Markets
1245 Luncheon & Exhibition Visits
1400 Sponsor Presentation Reserved
1430 Keynote Presentation
Evolution and Challenges of R&D Metrics at GSK
1515 Interactive Panel Discussion
Exploring Hidden Profits and Managing Contractual Partnerships across Asia
1600 Afternoon Refreshments & Networking Break
 “One-to-One” partnering meetings for big pharmas and CROs
1630 Keynote Presentation
Asia & Next Generation CROs
1700 CRO Roundtable
An Attractive Value Proposition to Big Pharmas? - Anticipating China's CROs Development Spree
1745 Chairman’s closing remarks
1800 Luxury Cocktail Party

Day Two - 18 September 2009, Friday
0800 Registration
0845 Chairman’s Welcome Address
0900 Keynote Presentation
New Dynamics of Strategic Alliances, M&A and Partnerships in Pharmaceutical - Biotechnology Industry
0940 Keynote Presentation
International Technology Transfer in the Pharmaceutical and Biotechnology Industries
1020 Keynote Presentation
Optimizing R&D Alliances between Pharmaceutical Companies and Academic Institutions
1100 Morning Refreshments & Networking Break
“One-to-One” partnering meetings for biotech CEOs and investors
1130 Keynote Presentation
Where is the Money? Recognizing the Role of VCPE in Funding Innovation
1200 Mastermind Panel on Investment
China Development Scenarios for Life Sciences: the New Eldorado?
1245 Luncheon
1400 Option one: Specially-arranged on-site visits to Zhangjiang based big pharmas and CROs
Option two: Project / product introduction meetings
1800 End of Summit
Who should attend?
Presidents, Vice Presidents, Directors, Senior Managers, Managers and Scientific Officers in charge of:
• Global Licensing / Business Development
• Strategic Planning
• Corporate Partnership
• Intellectual Property & Patents
• Research & Development
• Clinical Trials / Pre-clinical Development
• Sales and Marketing
For more information, please contact:
Ms. Anita MENG, Marketing Manager
Tel: (8621)6875 8108
Fax: (8621)6875 8750
Email: anitam@cfeci.com
Website: http://www.cfeci.com/wpcs2009

Venue